Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

NIH - National Institutes of Health National Cancer Institute Division of Cancer Treatment and Diagnosis Center for Cancer Research
NCI Experimental Therapeutics Program (NExT)
Contact NExT
Show menu
Search this site
Last Updated: 06/28/18

Discovery Activities in CCR

The Center for Cancer Research (CCR) is the basic and clinical research arm of the National Cancer Institute’s Intramural Program. Home to more than 250 scientists and clinicians, the CCR provides a unique community of researchers who work together to advance our knowledge of cancer and AIDS and to translate fundamental discoveries into novel therapies for patients. Discovery within CCR flows from investigator-initiated research, programs, and initiatives.

Examples of discovery work at the CCR include:

  • The Molecular Targets Laboratory conducts research in structural biology, chemical biology, molecular target screening, and natural product discovery
  • The Center for Advanced Preclinical Research evaluates the anti-tumor efficacy and selectivity, biodistribution, and metabolism of early-stage candidate drugs using genetically engineered mouse (GEM) models.
  • The Molecular Imaging Program focuses on developing and testing new imaging agents
  • The Gene Silencing Section collaboratively conducts synthetic siRNA-based RNAi screens
  • A trans-NIH Initiative at the NIH Chemical Genomics Center is developing large-scale siRNA-based RNAi screening

Visit CCR News for recent highlighted CCR Activities.

To learn more about our investigator’s research, please visit the CCR Website.